FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220682577> ?p ?o ?g. }

• W4220682577 endingPage "3500" @default.
• W4220682577 startingPage "3492" @default.
• W4220682577 abstract "Polypharmacy is commonly related to poor drug adherence, decreased quality of life and inappropriate prescribing in eldery. Furthermore, this condition also leads to a higher utilization of health services resources, due to the increased risk of adverse drug events, length of stays in hospitals and readmissions rates after discharge. This Systematic Review aimed to synthesize the current evidence that evaluates pharmaceutical services on polymedicated patients, from an economic perspective. Systematic searches were conducted in MEDLINE, SCOPUS and Cochrane Library databases to identify studies that were published until January 2021. Experimental and observational studies were included in this review, using strict inclusion/exclusion criteria and were assessed for quality using the following tools: RoB and ROBINS-I. Two independent reviewers selected the articles and extracted the data. 3,662 articles were retrieved from the databases. After the screening, 18 studies were included: 9 experimental and 9 observational studies. The studies reported that the integration of the pharmacist as a member of the healthcare team provides an optimized use of pharmacotherapy to polymedicated patients and contributes to health promotion, providing reduction of spending on medication, reduction of expenses related to emergency care and hospitalizations and other medical expenses. The ECRs made cost-effectiveness or cost-benefit analysis, and most of the Non Randomized studies had statistically significant cost savings even considering the expenses of pharmaceutical assistance. Experimental studies reported a cost reduction varying between US$ 193 to US$ 4,966 per patient per year. Furthermore, observational studies estimated a cost reduction of varying from US$ 3 to US$ 2,505 per patient per year. The cost savings are related to decrease in emergency visits and hospitalizations, through pharmacist intervention (medication review and pharmacotherapy follow-up). Considering the set of studies included, pharmaceutical care services directed to polymedicated patients may cooperate to save financial resources. Most of the interventions showed positive economic trends and also contributed to improving clinical parameters and quality of life. However, due to the majority of the studies having exploratory or qualitative methodology, it is essential to carry out more robust studies, based on full economic evaluation." @default.
• W4220682577 created "2022-04-03" @default.
• W4220682577 creator A5017122958 @default.
• W4220682577 creator A5017680595 @default.
• W4220682577 creator A5033175200 @default.
• W4220682577 creator A5069231075 @default.
• W4220682577 creator A5079543490 @default.
• W4220682577 date "2022-09-01" @default.
• W4220682577 modified "2023-10-01" @default.
• W4220682577 title "Economic impact of pharmaceutical services on polymedicated patients: A systematic review" @default.
• W4220682577 cites W1964593899 @default.
• W4220682577 cites W1973019412 @default.
• W4220682577 cites W1974733156 @default.
• W4220682577 cites W1978483154 @default.
• W4220682577 cites W2004320241 @default.
• W4220682577 cites W2019876752 @default.
• W4220682577 cites W2026988948 @default.
• W4220682577 cites W2031367983 @default.
• W4220682577 cites W2035636901 @default.
• W4220682577 cites W2052084025 @default.
• W4220682577 cites W2090571531 @default.
• W4220682577 cites W2090602898 @default.
• W4220682577 cites W2106191825 @default.
• W4220682577 cites W2140717488 @default.
• W4220682577 cites W2161228932 @default.
• W4220682577 cites W2164051725 @default.
• W4220682577 cites W2170785760 @default.
• W4220682577 cites W2171200514 @default.
• W4220682577 cites W2171421827 @default.
• W4220682577 cites W2246213013 @default.
• W4220682577 cites W2388398465 @default.
• W4220682577 cites W2417682611 @default.
• W4220682577 cites W2471640201 @default.
• W4220682577 cites W2508271679 @default.
• W4220682577 cites W2514375941 @default.
• W4220682577 cites W2529047839 @default.
• W4220682577 cites W2551817902 @default.
• W4220682577 cites W2560438049 @default.
• W4220682577 cites W2586565708 @default.
• W4220682577 cites W2617799736 @default.
• W4220682577 cites W2621247255 @default.
• W4220682577 cites W2773031587 @default.
• W4220682577 cites W2792631875 @default.
• W4220682577 cites W2799783487 @default.
• W4220682577 cites W2896148490 @default.
• W4220682577 cites W2896420893 @default.
• W4220682577 cites W2904202264 @default.
• W4220682577 cites W2912852492 @default.
• W4220682577 cites W2965606963 @default.
• W4220682577 cites W3011310061 @default.
• W4220682577 doi "https://doi.org/10.1016/j.sapharm.2022.03.005" @default.
• W4220682577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35337757" @default.
• W4220682577 hasPublicationYear "2022" @default.
• W4220682577 type Work @default.
• W4220682577 citedByCount "3" @default.
• W4220682577 countsByYear W42206825772023 @default.
• W4220682577 crossrefType "journal-article" @default.
• W4220682577 hasAuthorship W4220682577A5017122958 @default.
• W4220682577 hasAuthorship W4220682577A5017680595 @default.
• W4220682577 hasAuthorship W4220682577A5033175200 @default.
• W4220682577 hasAuthorship W4220682577A5069231075 @default.
• W4220682577 hasAuthorship W4220682577A5079543490 @default.
• W4220682577 hasConcept C104863432 @default.
• W4220682577 hasConcept C126322002 @default.
• W4220682577 hasConcept C142724271 @default.
• W4220682577 hasConcept C160735492 @default.
• W4220682577 hasConcept C162324750 @default.
• W4220682577 hasConcept C17744445 @default.
• W4220682577 hasConcept C177713679 @default.
• W4220682577 hasConcept C199539241 @default.
• W4220682577 hasConcept C204787440 @default.
• W4220682577 hasConcept C23131810 @default.
• W4220682577 hasConcept C2776478404 @default.
• W4220682577 hasConcept C2777596629 @default.
• W4220682577 hasConcept C2779457091 @default.
• W4220682577 hasConcept C2779473830 @default.
• W4220682577 hasConcept C36434225 @default.
• W4220682577 hasConcept C50522688 @default.
• W4220682577 hasConcept C512399662 @default.
• W4220682577 hasConcept C545542383 @default.
• W4220682577 hasConcept C71924100 @default.
• W4220682577 hasConcept C83867959 @default.
• W4220682577 hasConceptScore W4220682577C104863432 @default.
• W4220682577 hasConceptScore W4220682577C126322002 @default.
• W4220682577 hasConceptScore W4220682577C142724271 @default.
• W4220682577 hasConceptScore W4220682577C160735492 @default.
• W4220682577 hasConceptScore W4220682577C162324750 @default.
• W4220682577 hasConceptScore W4220682577C17744445 @default.
• W4220682577 hasConceptScore W4220682577C177713679 @default.
• W4220682577 hasConceptScore W4220682577C199539241 @default.
• W4220682577 hasConceptScore W4220682577C204787440 @default.
• W4220682577 hasConceptScore W4220682577C23131810 @default.
• W4220682577 hasConceptScore W4220682577C2776478404 @default.
• W4220682577 hasConceptScore W4220682577C2777596629 @default.
• W4220682577 hasConceptScore W4220682577C2779457091 @default.
• W4220682577 hasConceptScore W4220682577C2779473830 @default.
• W4220682577 hasConceptScore W4220682577C36434225 @default.
• W4220682577 hasConceptScore W4220682577C50522688 @default.

• next